abstract
- The author offers a perspective on the perceived conflicts of interest that influence scientific collaborations between academic psychiatry and the pharmaceutical industry. The author holds the position that the merits of a particular study should be judged based on the quality of the scientific methodology rather than on the credentials of the investigators or the source of funding.